We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
- Authors
Blazing, Michael A; de Lemos, James A; White, Harvey D; Fox, Keith A A; Verheugt, Freek W A; Ardissino, Diego; DiBattiste, Peter M; Palmisano, Joanne; Bilheimer, David W; Snapinn, Steven M; Ramsey, Karen E; Gardner, Laura H; Hasselblad, Vic; Pfeffer, Marc A; Lewis, Eldrin F; Braunwald, Eugene; Califf, Robert M; 'A to Z' Investigators
- Abstract
Enoxaparin or the combination of glycoprotein IIb/IIIa inhibitor tirofiban with unfractionated heparin independently have shown superior efficacy over unfractionated heparin alone in patients with non-ST-elevation acute coronary syndromes (ACS). It is not clear if combining enoxaparin with glycoprotein IIb/IIIa inhibitors is as safe or as effective as the current standard combination of unfractionated heparin with glycoprotein IIb/IIIa inhibitors.
- Publication
JAMA, 2004, Vol 292, Issue 1, p55
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.292.1.55